#ACSFall2020 will see our CEO, Andrew Sinclair, present on the Economics of Intensified/Continuous Downstream Processing" -hot topic- and very relevant to the intense pressures on #biologics manufacturing currently. Please engage with the presentation or follow us for more info
Global access to #COVIDใผ19#vaccine - how the vaccine is manufactured will govern the facilities required and the eventual cost sustainability - see this blog related to the Oxford adenovirus vaccine
#processmodelling, #biosolve
https://t.co/5Ju1qJJ6b1
An analysis of anti-#covid19#biologics manufacturing capacity/cost for 7.5M treatment (10 tons). #processmodelling with mAb platform (@Biophorum , #biosolve) - 1$B global investment required now; $75 COGS per treatment
https://t.co/T9OsvdmXZ8